Royal GD, Deventer, The Netherlands.
Department of Farm Animal Health, Veterinary Faculty, Utrecht University, Utrecht, The Netherlands.
Avian Pathol. 2022 Jun;51(3):244-256. doi: 10.1080/03079457.2022.2040731. Epub 2022 Mar 7.
To achieve long term protection of laying and breeding hens against aberrant egg production caused by infectious bronchitis virus (IBV), a vaccination programme incorporating both live-attenuated and inactivated IBV vaccines is required. High quality IBV vaccines of both types are widely available, but the number of IBV variants of global importance continues to increase and it is not possible to develop vaccines against each one of them. Therefore, it is desirable to perform studies under controlled conditions to determine which IBV vaccine(s) provide the best protection for laying hens against different IBV challenges. Previous vaccination and challenge studies have shown that it is possible to obtain relevant data in a small number of laying hens housed under conditions of strict isolation. The present work extends this finding by investigating the efficacy, against challenge with five IBV strains of global importance, of an IBV vaccination programme including two live-attenuated IBV vaccines (Massachusetts and 793B types) and three different commercially available inactivated vaccines each containing antigen against at least one IBV strain. The results reported here confirm the importance of IBV vaccination for laying hens, show that efficient live priming makes a beneficial contribution to this protection and confirm that inactivated IBV vaccines contribute significantly to effective protection against at least the five IBV challenge strains used here. Furthermore, we provide data to support the "protectotype concept", long-established using different live-attenuated IBV vaccines in young chickens, is valid in broadening protection against IBV challenges in laying birds.RESEARCH HIGHLIGHTSIBV vaccination is essential as an aid in protecting laying hens against IBV infection.Live priming is a beneficial part of the IBV vaccination programme.IBV inactivated vaccine improves IBV protection.Heterologous IBV protection is confirmed in laying hens.
为了长期保护产蛋和繁殖母鸡免受传染性支气管炎病毒(IBV)引起的异常产蛋,需要结合使用减毒活疫苗和灭活疫苗的疫苗接种计划。高质量的两种类型的 IBV 疫苗都广泛可用,但具有全球重要性的 IBV 变体数量继续增加,不可能针对每一种变体开发疫苗。因此,在受控条件下进行研究以确定哪种 IBV 疫苗可为产蛋母鸡提供针对不同 IBV 挑战的最佳保护是可取的。以前的疫苗接种和挑战研究表明,在严格隔离条件下饲养少量产蛋母鸡,有可能获得相关数据。本工作通过研究包括两种减毒活 IBV 疫苗(马萨诸塞州和 793B 型)和三种不同的市售灭活疫苗在内的 IBV 疫苗接种计划对 5 种具有全球重要性的 IBV 菌株的挑战的功效,扩展了这一发现。每个灭活疫苗均含有针对至少一种 IBV 株的抗原。这里报道的结果证实了 IBV 疫苗接种对产蛋母鸡的重要性,表明有效的活疫苗接种对此保护有有益的贡献,并证实灭活 IBV 疫苗对至少 5 种在此使用的 IBV 挑战株的有效保护有重要贡献。此外,我们提供的数据支持了“保护原型概念”,该概念在使用不同的减毒活 IBV 疫苗对小鸡进行的长期研究中是有效的,它拓宽了对产蛋鸟类中 IBV 挑战的保护。研究亮点 IBV 疫苗接种是保护产蛋母鸡免受 IBV 感染的重要辅助手段。活疫苗接种是 IBV 疫苗接种计划的有益组成部分。IBV 灭活疫苗可改善 IBV 保护。在产蛋母鸡中证实了异源 IBV 保护。